AFP and hepatocellular carcinoma: When we stratified the HCC patients by AFP level, the results demonstrated that prognostic value of CD155 remained in AFP ≤400 ng/ml subgroup (5‐year TTR rate CD155high vs. CD155low: 46.9% vs. 61.4%, p = .028).